By Joyce Frieden, News Editor, MedPage Today WASHINGTON — The FDA has approved the first meningococcal vaccine for use in toddlers and infants as young as nine months of age. The vaccine, called Menactra, is already approved for use in people ages 2 through 55 for prevention of invasive meningococcal disease caused by Neisseria meningitidis […]
Study to Assess Vaccine Safety During Pregnancy
By Iain Woessner TUCSON, Ariz. — The Arizona Pregnancy Riskline, a statewide nonprofit organization, announced a new national study to assess the safety of receiving the meningitis vaccine during pregnancy. The APR, based out of the University of Arizona College of Pharmacy, said in a news release that the launch of the study coincides with […]
Pilot project improved adolescent immunization rates
WASHINGTON — A pilot project in North Carolina among 18 health centers increased adolescent immunization coverage rates by 26% in 1 month, according to data presented here this week. The project was designed to increase age-appropriate immunization rates for the tetanus-diphtheria-pertussis vaccine, meningococcal conjugate vaccine (Menactra, Sanofi-Pasteur) and human papillomavirus vaccine and was conducted through […]
CDC to Study Vaccines and Autism
Huffingtonpost
David Kirby
Author/Journalist
Posted: March 18, 2011 05:46 PM
The Centers for Disease Control and Prevention wants to study autism as a possible clinical outcome of immunization, as part of its newly adopted 5-year research agenda for vaccine safety, the agency said on its website.
The CDC will also study mitochondrial dysfunction and the potential risk for post-vaccine “neurological deterioration,” and convene an expert panel on the feasibility of studying health outcomes such as autism among vaccinated and unvaccinated children.
The CDC plan adopts recommendations approved by the National Vaccine Advisory Committee of the US Department of Health and Human Services. It also comes one month after the federal government’s leading autism body, the Interagency Autism Coordinating Committee (IACC), announced a shift in research priorities toward environmental triggers for autism, which the IACC said could include toxins, biological agents and “adverse events following immunization.”
The Centers for Disease Control and Prevention’s Immunization Safety Office Scientific Agenda indentified the need to research “Neurodevelopmental disorders, including autism spectrum disorder (ASD)” as a possible clinical outcome of vaccination.
THE GREATER GOOD
A Documentary Film THE GREATER GOOD looks behind the fear, hype and politics that have polarized the vaccine debate in America today. The film re-frames the emotionally charged issue and offers, for the first time, the opportunity for a rational and scientific discussion on how to create a safer and more effective vaccine program. Latest […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 10
- Next Page »
